Jenny Zhang

SCH 503034, a Novel Hepatitis C Virus Protease Inhibitor, Plus Pegylated Interferon α-2b for Genotype 1 Nonresponders

Christoph Sarrazin, Frank Wagner, Nicole Forestier et al. · Gastroenterology · 2007 · 311 citations

Hepatology, Viral Hepatitis, Immunology +10

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials

Alan F. Barker, Anne E. O’Donnell, Patrick A. Flume et al. · The Lancet Respiratory Medicine · 2014 · 210 citations

Non-cystic Fibrosis Bronchiectasis, Allergy, Placebo-controlled Phase 3 +6

U.S. Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab

Steven J. Lemery, Jenny Zhang, Mark D. Rothmann et al. · Clinical Cancer Research · 2010 · 90 citations · Full text

A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study Results

Michael J. Kozal, Sergio Lupo, Edwin DeJesus et al. · HIV Clinical Trials · 2012 · 85 citations

Compression therapy affects collagen type balance in hypertrophic scar

Shawn Tejiram, Jenny Zhang, Taryn E Travis et al. · Journal of Surgical Research · 2015 · 71 citations · Full text

Fibrosis, Collagen Type Balance, Wound Healing +5